Genevant
Founded Year
2017About Genevant
Genevant is the developer of a lipid nanoparticle platform that enables clinical development of advanced RNA-based therapeutics. Its LNP platform is a clinically-validated LNP delivery technology with safety and efficacy evaluated across multiple clinical programs.
Genevant Headquarter Location
100 Cambridge St.
Cambridge, Massachusetts,
United States
Genevant Patents
Genevant has filed 8 patents.
The 3 most popular patent topics include:
- Biotechnology
- Molecular biology
- Polymers
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/21/2016 | 1/11/2022 | Clusters of differentiation, Immunology, Molecular biology, Transcription factors, Immune system | Grant |
Application Date | 1/21/2016 |
|---|---|
Grant Date | 1/11/2022 |
Title | |
Related Topics | Clusters of differentiation, Immunology, Molecular biology, Transcription factors, Immune system |
Status | Grant |
Latest Genevant News
May 10, 2022
Company profile: Genevant is a technology-focused nucleic acid delivery company with world-class platforms, the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate, and decades of experience and expertise […] The post Senior/Principal Scientist, Pharmaceutical Sciences appeared first on Life Sciences British Columbia.
Genevant Web Traffic
Genevant Rank
When was Genevant founded?
Genevant was founded in 2017.
Where is Genevant's headquarters?
Genevant's headquarters is located at 100 Cambridge St., Cambridge.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.